Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Viral hepatitis.

× No keyword cloud information.

6 in total

1. Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies.

Authors: Isabel Fofana; Samira Fafi-Kremer; Patric Carolla; Catherine Fauvelle; Muhammad Nauman Zahid; Marine Turek; Laura Heydmann; Karine Cury; Juliette Hayer; Christophe Combet; François-Loïc Cosset; Thomas Pietschmann; Marie-Sophie Hiet; Ralf Bartenschlager; François Habersetzer; Michel Doffoël; Zhen-Yong Keck; Steven K H Foung; Mirjam B Zeisel; Françoise Stoll-Keller; Thomas F Baumert
Journal: Gastroenterology Date: 2012-04-10 Impact factor: 22.682

2. Expression and Ni-NTA-Agarose Purification of Recombinant Hepatitis C Virus E2Ectodomain Produced in a Baculovirus Expression System.

Authors: Julián Gómez-Gutiérrez; Mar Rodríguez-Rodríguez; Francisco Gavilanes; Belén Yélamos
Journal: Bio Protoc Date: 2018-10-05

3. Characterization of antigenic variants of hepatitis C virus in immune evasion.

Authors: Jane H Wang; Matthew J Pianko; Xiaogang Ke; Alex Herskovic; Ronald Hershow; Scott J Cotler; Weijin Chen; Zheng W Chen; Lijun Rong
Journal: Virol J Date: 2011-07-29 Impact factor: 4.099

4. Type of pegylated interferon matters: another milestone in the treatment of hepatitis C virus infection.

Authors: Ashwani Kumar Singal
Journal: Hepat Mon Date: 2010-09-01 Impact factor: 0.660

5. Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3.

Authors: Anna Pasetto; Lars Frelin; Anette Brass; Anila Yasmeen; Sarene Koh; Volker Lohmann; Ralf Bartenschlager; Isabelle Magalhaes; Markus Maeurer; Matti Sällberg; Margaret Chen
Journal: J Gen Virol Date: 2011-11-09 Impact factor: 3.891

6. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.

Authors: Prudence Ive; William MacLeod; Nompumelelo Mkumla; Catherine Orrell; Ute Jentsch; Carole L Wallis; Wendy Stevens; Robin Wood; Ian Sanne; Debika Bhattacharya
Journal: PLoS One Date: 2013-12-06 Impact factor: 3.240

6 in total